Potential biological pathways linking Type-D personality and poor health: A cross-sectional investigation
Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
28453522
PubMed Central
PMC5409166
DOI
10.1371/journal.pone.0176014
PII: PONE-D-15-53736
Knihovny.cz E-zdroje
- MeSH
- autonomní nervový systém fyziologie MeSH
- dospělí MeSH
- glukosa metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- osobnost typu D * MeSH
- průřezové studie MeSH
- spánek MeSH
- zdravé chování MeSH
- zdraví * MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- glukosa MeSH
BACKGROUND: Type-D personality, defined as a combination of high negative affect and high social isolation, has been associated with poor health outcomes. However, pathways underlying this association are largely unknown. We investigated the relationship between Type-D personality and several biological and behavioral pathways including the autonomic nervous system, the immune system, glucose regulation and sleep in a large, apparently healthy sample. METHODS: Data from a total of 646 respondents (age 41.6±11.5, 12,2% women) were available for analysis. Persons with Type-D (negative affect and social isolation score ≥10) were contrasted with those without Type-D. Measures of plasma fibrinogen levels, white blood cell count, high sensitivity C-reactive protein, fasting plasma glucose (FPG), cholesterol, high-density and low-density lipoprotein, glycated hemoglobin (HbA1c), creatinine, triglycerides, and albumin were derived from fasting blood samples. Urine norepinephrine and free cortisol were determined by high-performance liquid chromatography. Time-domain heart rate variability (HRV) measures were calculated for the 24hr recording period and for nighttime separately. RESULTS: Persons with Type-D had higher HbA1c, FPG, and fibrinogen, and lower nighttime HRV than those without Type-D, suggesting worse glycemic control, systemic inflammation and poorer autonomic nervous system modulation in Type-D persons. In addition, those with Type-D reported less social support and greater sleep difficulties while no group differences were observed for alcohol and cigarette consumption, physical activity and body mass index. CONCLUSIONS: Findings provide some of the first evidence for multiple possible biological and behavioral pathways between Type-D personality and increased morbidity and mortality.
Department of Internal Medicine Faculty of Medicine University of Ostrava Ostrava Czech Republic
Department of Psychology The Ohio State University Columbus Ohio United States of America
Zobrazit více v PubMed
Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med.; 2005;67(1):89–97. doi: 10.1097/01.psy.0000149256.81953.49 PubMed DOI
Denollet J, Pedersen SS, Ong ATL, Erdman RAM, Serruys PW, van Domburg RT. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur Heart J. 2006; 27(2):171–7. doi: 10.1093/eurheartj/ehi616 PubMed DOI
Mols F, Denollet J. Type D personality among noncardiovascular patient populations: a systematic review. Gen Hosp Psychiatry . Elsevier Inc.; 2010;32(1):66–72. PubMed
Dulfer K, Hazemeijer BAF, Van Dijk MR, Van Geuns RJM, Daemen J, Van Domburg RT, et al. Prognostic value of type D personality for 10-year mortality and subjective health status in patients treated with percutaneous coronary intervention. J Psychosom Res. 2015; 79(3):214–21. doi: 10.1016/j.jpsychores.2015.05.014 PubMed DOI
Grande G, Romppel M, Barth J. Association between type D personality and prognosis in patients with cardiovascular diseases: a systematic review and meta-analysis. Ann Behav Med. 2012; 43(3):299–310. doi: 10.1007/s12160-011-9339-0 PubMed DOI
Mommersteeg PMC, Pelle AJ, Ramakers C, Szabó BM, Denollet J, Kupper N. Type D personality and course of health status over 18 months in outpatients with heart failure: multiple mediating inflammatory biomarkers. Brain Behav Immun. 2012; 26(2):301–10. doi: 10.1016/j.bbi.2011.09.010 PubMed DOI
Kupper N, Pelle AJ, Szabó BM, Denollet J. The relationship between Type D personality, affective symptoms and hemoglobin levels in chronic heart failure. PLoS One. 2013;8(3):e58370 doi: 10.1371/journal.pone.0058370 PubMed DOI PMC
Mommersteeg PMC, Herr R, Bosch J, Fischer JE, Loerbroks A. Type D personality and metabolic syndrome in a 7-year prospective occupational cohort. J Psychosom Res. 2011; 71(5):357–63. doi: 10.1016/j.jpsychores.2011.05.004 PubMed DOI
Tziallas D, Kostapanos MS, Skapinakis P, Milionis HJ, Athanasiou T, S Elisaf M, et al. The association between Type D personality and the metabolic syndrome: a cross-sectional study in a University-based outpatient lipid clinic. BMC Res Notes. 2011;4(1):105. PubMed PMC
Armon G. Type D personality and job burnout: The moderating role of physical activity. Pers Individ Dif. 2014;58:112–5.
Condén E, Ekselius L, Aslund C. Type D personality is associated with sleep problems in adolescents. Results from a population-based cohort study of Swedish adolescents. J Psychosom Res. 2013; 74(4):290–5. doi: 10.1016/j.jpsychores.2012.11.011 PubMed DOI
Mommersteeg PMC, Kupper N, Denollet J. Type D personality is associated with increased metabolic syndrome prevalence and an unhealthy lifestyle in a cross-sectional Dutch community sample. BMC Public Health. 2010;10(1):714. PubMed PMC
Kupper N, Pelle A, Denollet J. Association of Type D personality with the autonomic and hemodynamic response to the cold pressor test. Psychophysiology. 2013; 50(12):1194–201. doi: 10.1111/psyp.12133 PubMed DOI
Task Force of the European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996; 17:354–81. PubMed
Schuster AK, Fischer JE, Thayer JF, Mauss D, Jarczok MN. Decreased heart rate variability correlates to increased cardiovascular risk. Int J Cardiol.2016;203:728–30. doi: 10.1016/j.ijcard.2015.11.027 PubMed DOI
Jandackova VK, Scholes S, Britton A, Steptoe A. Are Changes in Heart Rate Variability in Middle-Aged and Older People Normative or Caused by Pathological Conditions? Findings From a Large Population-Based Longitudinal Cohort Study. J Am Heart Assoc. 2016;5(2):e002365 doi: 10.1161/JAHA.115.002365 PubMed DOI PMC
Thayer JF, Fischer JE. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med. 2009;265(4):439–47. doi: 10.1111/j.1365-2796.2008.02023.x PubMed DOI
Thayer JF, Fischer JE. Heart rate variability, overnight urinary norepinephrine, and plasma cholesterol in apparently healthy human adults. Int J Cardiol. 2013, 3;162:240–4. doi: 10.1016/j.ijcard.2011.05.058 PubMed DOI
Werner GG, Ford BQ, Mauss IB, Schabus M, Blechert J, Wilhelm FH. High cardiac vagal control is related to better subjective and objective sleep quality. Biol Psychol. 2015;106:79–85. doi: 10.1016/j.biopsycho.2015.02.004 PubMed DOI PMC
Jandackova VK, Britton A, Malik M, Steptoe A. Heart rate variability and depressive symptoms: a cross-lagged analysis over a 10-year period in the Whitehall II study. Psychol Med. 2016;46(10):2121–31. doi: 10.1017/S003329171600060X PubMed DOI
Jarczok MN, Kleber ME, Koenig J, Loerbroks A, Herr RM, Hoffmann K, et al. Investigating the associations of self-rated health: heart rate variability is more strongly associated than inflammatory and other frequently used biomarkers in a cross sectional occupational sample. PLoS One. 2015; 10(2):e0117196 doi: 10.1371/journal.pone.0117196 PubMed DOI PMC
Jarczok MN, Koenig J, Schuster AK, Thayer JF, Fischer JE. Nighttime heart rate variability, overnight urinary norepinephrine, and glycemic status in apparently healthy human adults. Int J Cardiol. 2013. 3;168(3):3025–6. doi: 10.1016/j.ijcard.2013.04.147 PubMed DOI
Martin L a, Doster J a, Critelli JW, Lambert PL, Purdum M, Powers C, et al. Ethnicity and Type D personality as predictors of heart rate variability. Int J Psychophysiol. 2010;76(2):118–21. doi: 10.1016/j.ijpsycho.2010.03.001 PubMed DOI
Hoogwegt MT, Pedersen SS, Theuns D a MJ, Kupper N. Relation between emotional distress and heart rate variability in patients with an implantable cardioverter-defibrillator. Psychophysiology. 2014; 51(2):187–96. doi: 10.1111/psyp.12158 PubMed DOI
Einvik G, Dammen T, Namtvedt SK, Hrubos-Strom H, Randby A, Kristiansen HA, et al. Type D personality is associated with increased prevalence of ventricular arrhythmias in community-residing persons without coronary heart disease. Eur J Prev Cardiol. 2014;21(5):592–600. doi: 10.1177/2047487312462800 PubMed DOI
Kopp WJ, Stein PK, Tracy RP, Barzilay JI, Schulz R, Gottdiener JS. Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med. 2010; 72(7):626–35. doi: 10.1097/PSY.0b013e3181eadd2b PubMed DOI PMC
Emons WHM, Meijer RR, Denollet J. Negative affectivity and social inhibition in cardiovascular disease: Evaluating type-D personality and its assessment using item response theory. J Psychosom Res. 2007;63(1):27–39. doi: 10.1016/j.jpsychores.2007.03.010 PubMed DOI
Denollet J, Kupper N. Stress and the heart: the role of type D personality in personalized care. Eur Heart J. 2015;36(28):1783–5. PubMed
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Centre; 1993.
Bullinger M. German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. Soc Sci Med. 1995; 41(10):1359–66. PubMed
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res. 2002;52(2):69–77. PubMed
Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988;41(4):313–21. PubMed
Mackie IJ, Kitchen S, Machin SJ, Lowe GDO. Guidelines on fibrinogen assays. Br J Haematol. 2003;121(3):396–404. PubMed
NIH: U.S. National Library of Medicine [Internet]. Medical encyclopedia. 2016. Available from: https://medlineplus.gov/ency
Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43–6. PubMed
Rothman KJ. Six persistent research misconceptions. J Gen Intern Med. 2014;29(7):1060–4. doi: 10.1007/s11606-013-2755-z PubMed DOI PMC
Saville D. Multiple Comparison Procedures: The Practical Solution. 1990;44:174–80.
Khaw K-T, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141(6):413–20. PubMed
Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800–11. doi: 10.1056/NEJMoa0908359 PubMed DOI PMC
Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care. 2011;34(2):518–23. doi: 10.2337/dc10-1546 PubMed DOI PMC
Graham MR, Evans P, Thomas N-E, Davies B, Baker JS. Changes in endothelial dysfunction and associated cardiovascular disease morbidity markers in GH-IGF axis pathology. Am J Cardiovasc Drugs. New Zealand. 2009;9(6):371–81. doi: 10.2165/11312100-000000000-00000 PubMed DOI
Kaptoge S, White IR, Thompson SG, Wood AM, Lewington S, Lowe GDO, et al. Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies colla. Am J Epidemiol. United States; 2007;166(8):867–79. doi: 10.1093/aje/kwm191 PubMed DOI
Steptoe A, Brydon L. Emotional triggering of cardiac events. Neurosci Biobehav Rev. 2009. February;33(2):63–70. doi: 10.1016/j.neubiorev.2008.04.010 PubMed DOI
Einvik G, Dammen T, Hrubos-Strom H, Namtvedt SK, Randby A, Kristiansen HA et al. Prevalence of cardiovascular risk factors and concentration of C-reactive protein in Type D personality persons without cardiovascular disease. Eur J Cardiovasc Prev Rehabil. 2011;18(3):504–9. doi: 10.1177/1741826710389383 PubMed DOI
Kanel R Von, Thayer JF, Fischer JE. Nighttime Vagal Cardiac Control and Plasma Fibrinogen Levels in a Population of Working Men and Women. Ann Noninvasive Electrocardiol. 2009;14(2):176–84. doi: 10.1111/j.1542-474X.2009.00293.x PubMed DOI PMC
Tracey KJ. The inflammatory reflex. Nature. England; 2002. December;420(6917):853–9. doi: 10.1038/nature01321 PubMed DOI
Pocai A, Lam TKT, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature.2005;434(7036):1026–31. doi: 10.1038/nature03439 PubMed DOI
Thayer JF, Brosschot JF. Psychosomatics and psychopathology: looking up and down from the brain. Psychoneuroendocrinology. 2005;30(10):1050–8. doi: 10.1016/j.psyneuen.2005.04.014 PubMed DOI
Arch JJ, Brown KW, Dean DJ, Landy LN, Brown KD, Laudenslager ML. Self-compassion training modulates alpha-amylase, heart rate variability, and subjective responses to social evaluative threat in women. Psychoneuroendocrinology. 2014;42:49–58. doi: 10.1016/j.psyneuen.2013.12.018 PubMed DOI PMC
Thayer JF, Ahs F, Fredrikson M, Sollers JJ, Wager TD. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev. 2012;36(2):747–56. doi: 10.1016/j.neubiorev.2011.11.009 PubMed DOI
Ohman A, Mineka S. Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychol Rev. 2001;108(3):483–522. PubMed
Elsenbruch S, Schmid J, Kullmann JS, Kattoor J, Theysohn N, Forsting M et al. Visceral sensitivity correlates with decreased regional gray matter volume in healthy volunteers: a voxel-based morphometry study. Pain. 2014;155(2):244–9. doi: 10.1016/j.pain.2013.09.027 PubMed DOI
Page KA, Seo D, Belfort-DeAguiar R, Lacadie C, Dzuira J, Naik S et al. Circulating glucose levels modulate neural control of desire for high-calorie foods in humans. J Clin Invest. 2011;121(10):4161–9. doi: 10.1172/JCI57873 PubMed DOI PMC
Soares-Miranda L, Sattelmair J, Chaves P, Duncan GE, Siscovick DS, Stein PK et al. Physical activity and heart rate variability in older adults: the Cardiovascular Health Study. Circulation. 2014. 27;129(21):2100–10. doi: 10.1161/CIRCULATIONAHA.113.005361 PubMed DOI PMC
Vonck K, Raedt R, Naulaerts J, De Vogelaere F, Thiery E, Van Roost D et al. Vagus nerve stimulation…25 years later! What do we know about the effects on cognition? Neurosci Biobehav Rev. 2014. September;45:63–71. doi: 10.1016/j.neubiorev.2014.05.005 PubMed DOI
Gremigni P, Sommaruga M. Type D personality, a relevant construct in cardiology Preliminary validation study of the Italian questionnaire. Psicot Cogn Comport. 2005;11:7–18.
Williams L, O’Connor RC, Howard S, Hughes BM, Johnston DW, Hay JL et al. Type-D personality mechanisms of effect: the role of health-related behavior and social support. J Psychosom Res. 2008; 64(1):63–9. doi: 10.1016/j.jpsychores.2007.06.008 PubMed DOI
Beutel ME, Wiltink J, Till Y, Wild PS, Münzel T, Ojeda FM et al. Type D personality as a cardiovascular risk marker in the general population: Results from the gutenberg health study. Psychother Psychosom. 2012;81(2):108–17. doi: 10.1159/000331776 PubMed DOI